Evidence map›Paper›PMID 25853442›Full record

ArticleEye (London, England)2015

Association of histone acetylation at the ACTA2 promoter region with epithelial mesenchymal transition of lens epithelial cells.

D A Ganatra, S Rajkumar, A R Patel, D U Gajjar, K Johar, A I Arora, F B Kayastha, A R Vasavada

Open access · bronzeAbstract read
In one paragraph

Article in Eye (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Role of epigenetics in corneal health and disease.Progress in retinal and eye research · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

D A GanatraCell and Molecular Biology, Iladevi Cataract and IOL Research Centre, Ahmedabad, India.
S RajkumarCell and Molecular Biology, Iladevi Cataract and IOL Research Centre, Ahmedabad, India.
A R PatelCell and Molecular Biology, Iladevi Cataract and IOL Research Centre, Ahmedabad, India.
D U GajjarCell and Molecular Biology, Iladevi Cataract and IOL Research Centre, Ahmedabad, India.
K JoharCell and Molecular Biology, Iladevi Cataract and IOL Research Centre, Ahmedabad, India.
A I AroraCell and Molecular Biology, Iladevi Cataract and IOL Research Centre, Ahmedabad, India.
F B KayasthaCell and Molecular Biology, Iladevi Cataract and IOL Research Centre, Ahmedabad, India.
A R VasavadaCell and Molecular Biology, Iladevi Cataract and IOL Research Centre, Ahmedabad, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeEpithelial mesenchymal transition (EMT) plays a central role in the development of fibrotic complications of the lens. The current study is designed to check whether EMT of lens epithelial cells (LECs) is regulated by epigenetic modifications and to evaluate the effect of Trichostatin-A (TSA) on the transforming growth factor-β (TGF-β)-induced EMT.

methodsFetal human LECs (FHL124) were treated with TGF-β2 in the presence or absence of TSA. Levels of mRNA, protein, as well as localization of α-smooth muscle actin (αSMA) were studied along with migration of LECs. Acetylation of histone H4 was analyzed and chromatin immunoprecipitation (ChIP) was carried out to study the level of acetylated histone H4 at the promoter of αSMA gene (ACTA2). Student's t-test was used for statistical analysis.

resultsTGF-β2 treatment resulted in myofibroblast-like changes and increased migratory capacity of FHL124. Protein and mRNA expression of αSMA increased, and immunofluorescence revealed presence of extensive stress fibers. TSA treatment preserved epithelial morphology, retarded cell migration, and abrogated an increase in αSMA levels. TSA led to the accumulation of acetylated histone H4 that was reduced on TGF-β2 treatment. However, increased level of histone H4 acetylation was found at the ACTA2 promoter region during TGF-β treatment.

conclusionsThe increased level of αSMA, a hallmark of EMT in LECs, is associated with increased level of histone H4 acetylation at its promoter region, and TSA helps in suppressing EMT by epigenetically reducing this level. TSA thus shows promising potential in management of fibrotic conditions of the lens.

Indexed as

Epithelial-Mesenchymal TransitionAcetylationActinsBlotting, WesternCell MovementCells, CulturedEpithelial CellsFetusFluorescent Antibody Technique, IndirectHistone Deacetylase InhibitorsHistonesHumansHydroxamic AcidsLens, CrystallinePromoter Regions, GeneticReal-Time Polymerase Chain ReactionACTA2 protein, humanActinsHistone Deacetylase InhibitorsHistonesHydroxamic AcidsRNA, MessengerTransforming Growth Factor beta2trichostatin A

Identifiers

PMID25853442
PMCPMC4469664
OpenAlexW2078945633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.